Halozyme Therapeutics (HALO) Misses Q4 EPS by 9c, Offers Guidance
Go back to Halozyme Therapeutics (HALO) Misses Q4 EPS by 9c, Offers Guidance| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 98.55 -2.12 (2.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $100.67 | 52 Week High | $18.39 | |||
| Open | $100.35 | 52 Week Low | $6.96 | |||
| Day High | $100.83 | P/E | N/A | |||
| Day Low | $98.13 | EPS | $-0.58 | |||
| Volume | 839,745 | |||||
